Pharma giants Merck, Eli Lilly face earnings health check (MRK:NYSE)
· seekingalpha.com
Preview Merck and Eli Lilly Q3 earnings: Keytruda risks, GLP-1 growth, guidance outlook, and key drugs to watch.
Pharmaceutical giants Merck (MRK) and Eli Lilly (LLY) are scheduled to report third-quarter results on October 29, with analysts expecting a year-on-year earnin...